Literature DB >> 10493561

In vitro and in vivo assessment of bone-implant interface: a comparative study.

A De Benedittis1, M Mattioli-Belmonte, A Krajewski, M Fini, A Ravaglioli, R Giardino, G Biagini.   

Abstract

The present in vitro and in vivo comparison of three bioactive (HA, AP40, RKKP) and three bioinert (Ti6-Al4-V, Al2O3, ZrO2) materials was undertaken to identify which of them provide(s) the most suitable coating for prostheses implanted in patients with altered metabolic status. The experimental design included in vitro tests with human osteoblasts and morphological observations by scanning electron microscopy. For the in vivo evaluation, the materials were implanted in the femoral condyle of ovariectomised and intact female rats, and two months after surgery an X-ray microanalytical study was performed. The in vitro study showed good biocompatibility with all materials. Microanalysis evidenced a similar behaviour with all materials except the two biological glasses. The differences in Ca and P content observed between intact and ovariectomised rats can be explained by the intrinsic capability of biological glasses to undergo surface modifications in the presence of alterations of the bone metabolism. Thus, their use seems to be indicated in recipients with osteoporotic pathologies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493561

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  2 in total

1.  The bio-functional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro.

Authors:  Huanjun Zhou; Jie Wei; Xiaohui Wu; Jianlin Shi; Changsheng Liu; Junfeng Jia; Chenglong Dai; Qi Gan
Journal:  J Mater Sci Mater Med       Date:  2010-04-22       Impact factor: 3.896

2.  Implants of polyanionic collagen matrix in bone defects of ovariectomized rats.

Authors:  Marcelo Rodrigues Cunha; Arnaldo Rodrigues Santos; Gilberto Goissis; Selma C Genari
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.